Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic
JADESTRESS
1 other identifier
observational
1,322
1 country
1
Brief Summary
Since the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and heightened demand for peri-urban housing offering more space and a better living environment. Queues of students at food distribution points, along with the precarious situations and isolation faced by students with no alternative to cramped living quarters, have exposed the vulnerability of this population to the general public. There is a lack of data regarding young people-and students in particular-a group known to be at higher risk than others of exhibiting symptoms of stress, anxiety, or depression. Depression among students and young adults can impact their social lives, relationships, and quality of life. Indeed, studies have demonstrated a strong correlation between major depressive disorder and poor academic performance, unstable interpersonal relationships, suicidal thoughts and attempts, and difficulties with work. Existing literature indicates a link between stress and the onset or persistence of anxiety and depression. As these conditions are too often conflated, it is important to distinguish stress from anxiety and depression. Consequently, a study designed to assess levels of stress, anxiety, and depression-as well as the processes involved in their development and persistence among young people-would facilitate the implementation of appropriate and effective care. Such a study is all the more necessary in the current context of the COVID-19 pandemic. Identifying these disorders within specific populations and subgroups would enable the implementation of tailored care strategies, thereby helping to safeguard mental health. The aim of this study is to assess current levels of stress, anxiety, and depression among young adults and students, and to investigate the underlying determinants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2023
CompletedFirst Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedSeptember 28, 2026
September 1, 2026
4 months
September 18, 2026
September 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Perceived Stress Scale (PSS) score :
The PSS-10 takes about 3 minutes to complete and produces a 0-40 score : * 0-13 low * 14-26 moderate * 27-40 high
3 months
Study Arms (1)
patient between 18 and 29 years old
Interventions
* Generalised anxiety disorder questionnaire * Questionnaire Patient Health Questionnaire-9 (PHQ-9) * Perceived Stress Scale questionnaire * Difficulties in Emotion Regulation Scale (DERS-16) questionnaire * Acceptance and action questionnaire * Perseverative Thinking Questionnaire * D-stress questionnaire * Electrostatic discharge questionnaire
Eligibility Criteria
Adult patient between 18 and 29 years old
You may qualify if:
- Subject between 18 and 29 years of age.
- Subject capable of understanding the information necessary for the study and participating in online surveys.
- Has read the information sheet describing the research and agreed to participate.
- Subject affiliated with or a beneficiary of a social security scheme.
You may not qualify if:
- Minor subject
- Subject aged 30 or older
- Difficulty understanding and/or expressing themselves in French
- Subject under legal protection measures (curatorship, guardianship, etc.) or deprived of liberty by judicial or administrative decision
- Pregnant, breastfeeding, or recently delivered woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Université de Nanterre
Nanterre, 92000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 28, 2026
Study Start
May 16, 2022
Primary Completion
September 26, 2022
Study Completion
January 27, 2023
Last Updated
September 28, 2026
Record last verified: 2026-09